MetLife Investment Management’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.26M Buy
46,331
+1,977
+4% +$96.6K 0.01% 938
2025
Q1
$2.26M Sell
44,354
-2,234
-5% -$114K 0.01% 985
2024
Q4
$2.1M Buy
46,588
+2,581
+6% +$117K 0.01% 1008
2024
Q3
$1.63M Hold
44,007
0.01% 1133
2024
Q2
$1.35M Buy
44,007
+6,827
+18% +$209K 0.01% 1185
2024
Q1
$1.08M Hold
37,180
0.01% 1253
2023
Q4
$1.02M Hold
37,180
0.01% 1277
2023
Q3
$833K Hold
37,180
0.01% 1341
2023
Q2
$1.51M Hold
37,180
0.01% 1052
2023
Q1
$1.8M Hold
37,180
0.01% 956
2022
Q4
$1.42M Hold
37,180
0.01% 1036
2022
Q3
$1.87M Buy
37,180
+276
+0.7% +$13.9K 0.02% 909
2022
Q2
$1.48M Sell
36,904
-1,535
-4% -$61.5K 0.01% 1026
2022
Q1
$1.43M Buy
38,439
+13,448
+54% +$502K 0.01% 1135
2021
Q4
$995K Hold
24,991
0.01% 1125
2021
Q3
$930K Hold
24,991
0.01% 1150
2021
Q2
$1.06M Buy
24,991
+1,477
+6% +$62.4K 0.01% 1133
2021
Q1
$1.11M Sell
23,514
-2,054
-8% -$97.3K 0.01% 1106
2020
Q4
$1.56M Sell
25,568
-1,698
-6% -$104K 0.01% 935
2020
Q3
$1.27M Hold
27,266
0.01% 922
2020
Q2
$1.38M Buy
27,266
+1,474
+6% +$74.8K 0.02% 891
2020
Q1
$1.15M Hold
25,792
0.02% 840
2019
Q4
$1.24M Hold
25,792
0.01% 985
2019
Q3
$872K Hold
25,792
0.01% 1138
2019
Q2
$1.16M Buy
25,792
+2,915
+13% +$131K 0.01% 1043
2019
Q1
$861K Buy
22,877
+1,827
+9% +$68.8K 0.01% 1145
2018
Q4
$722K Hold
21,050
0.01% 1160
2018
Q3
$989K Hold
21,050
0.01% 1126
2018
Q2
$710K Buy
21,050
+1,850
+10% +$62.4K 0.01% 1191
2018
Q1
$520K Hold
19,200
0.01% 1341
2017
Q4
$320K Buy
+19,200
New +$320K ﹤0.01% 1673